Chad Oh
Chief Tech/Sci/R&D Officer bei AEON BIOPHARMA, INC.
Vermögen: - $ am 31.03.2024
Profil
Chad K.
Oh is currently the Chief Medical Officer at AEON Biopharma Sub, Inc. and will also be the Chief Medical Officer at AEON Biopharma,.
Inc. starting in 2023.
Previously, he was the Vice President of Clinical Development at Revance Therapeutics, Inc. from 2017 to 2018 and the Vice President at KCBN Holding, Inc. from 2018 to 2021.
He was also the Chief of Allergy & Immunology at Harbor-UCLA Medical Center from 1995 to 2008.
Dr. Oh received his undergraduate degree from Kyung Hee University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Chad Oh
| Unternehmen | Position | Beginn |
|---|---|---|
| AEON BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 24.07.2023 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Chief Tech/Sci/R&D Officer | 01.06.2021 |
Ehemalige bekannte Positionen von Chad Oh
| Unternehmen | Position | Ende |
|---|---|---|
KCBN Holding, Inc.
 KCBN Holding, Inc. MiscellaneousMiscellaneous KCBN Holding, Inc. provides compliance services to the healthcare sector. The company is headquartered in Kansas City, MO. | Corporate Officer/Principal | 01.06.2021 |
| REVANCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2018 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Corporate Officer/Principal | 01.01.2008 |
Ausbildung von Chad Oh
| Kyung Hee University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| AEON BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Health Services |
KCBN Holding, Inc.
KCBN Holding, Inc. MiscellaneousMiscellaneous KCBN Holding, Inc. provides compliance services to the healthcare sector. The company is headquartered in Kansas City, MO. | Miscellaneous |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
